SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD Shanghai Kehua Bio-Engineering Co.,Ltd Share Price
Equities
002022
CNE000001KC9
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.31 CNY | +3.98% |
|
+7.50% | -35.76% |
| 15/04 | Kehua Bio-Engineering Gets Registration Certificates for Two Devices | MT |
| 02/04 | Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023. | CI |
| Sales 2022 | 6.97B 964M 80.42B | Sales 2023 | 2.43B 336M 28.01B | Capitalization | 5.85B 809M 67.53B |
|---|---|---|---|---|---|
| Net income 2022 | 971M 134M 11.2B | Net income 2023 | -234M -32.36M -2.7B | EV / Sales 2022 | 0.54 x |
| Net cash position 2022 | 2.61B 361M 30.1B | Net cash position 2023 | 1.04B 144M 12B | EV / Sales 2023 | 1.98 x |
| P/E ratio 2022 |
6.79
x | P/E ratio 2023 |
-25
x | Employees | 2,151 |
| Yield 2022 |
4.85% | Yield 2023 |
-
| Free-Float | 76.41% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.98% | ||
| 1 week | +7.50% | ||
| Current month | -8.28% | ||
| 1 month | -8.28% | ||
| 3 months | -11.50% | ||
| 6 months | -16.27% | ||
| Current year | -35.76% |
1 week
6.74
7.35
1 month
6.618.06
Current year
6.1911.78
1 year
6.1912.58
3 years
6.1919.82
5 years
6.1925.99
10 years
6.1964.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Li
PSD | President | 48 | 03/23/03 |
Fang Luo
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Dun Fang Chen
BRD | Director/Board Member | 50 | 01/09/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Ying Jin
BRD | Director/Board Member | 52 | 17/22/17 |
Zhi Chao Ma
CHM | Chairman | 44 | 21/22/21 |
Ming Li
PSD | President | 48 | 03/23/03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 7.31 | +3.98% | 6,198,150 |
| 26/24/26 | 7.03 | +0.14% | 3,903,100 |
| 25/24/25 | 7.02 | +1.89% | 3,967,200 |
| 24/24/24 | 6.89 | +0.58% | 3,330,100 |
| 23/24/23 | 6.85 | +0.74% | 3,976,597 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Shanghai Kehua Bio-engineering Co., Ltd. specializes in the development, manufacturing and marketing of diagnostic biological products. The group proposes primarily reagents, in vitro diagnostics agents, automated instruments of detection, etc.
China accounts for 91% of net sales.
Calendar
16/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.76% | 499M | |
| +1.69% | 12.8B | |
| -7.57% | 7.61B | |
| +3.22% | 5.41B | |
| +0.93% | 4.51B | |
| +8.48% | 4.49B | |
| +9.21% | 2.73B | |
| -13.87% | 2.02B | |
| -11.63% | 1.73B | |
| +3.45% | 1.64B |
- Stock Market
- Equities
- 002022 Stock
